We are live on ! Find out more
EWA

Evolution Wealth Advisors Portfolio holdings

AUM $981M
1-Year Est. Return 21.2%
This Fund
S&P 500
This Quarter Est. Return
-2.38%
1 Year Est. Return
+21.2%
3 Year Est. Return
+66.36%
5 Year Est. Return
+44.78%
10 Year Est. Return
AUM
$467M
AUM Growth
-$25.5M
Cap. Flow
-$10.1M
Cap. Flow %
-2.16%
Top 10 Hldgs %
56.62%
Holding
696
New
70
Increased
144
Reduced
141
Closed
33

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 4.08%
2 Technology 3.44%
3 Communication Services 1.92%
4 Financials 1.84%
5 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
D icon
501
Dominion Energy
D
$62.5B
$5K ﹤0.01%
73
DGX icon
502
Quest Diagnostics
DGX
$23.2B
$5K ﹤0.01%
34
-67
-66% -$9.8K
DOW icon
503
Dow Inc
DOW
$22.5B
$5K ﹤0.01%
81
ED icon
504
Consolidated Edison
ED
$41.3B
$5K ﹤0.01%
67
EFX icon
505
Equifax
EFX
$20.3B
$5K ﹤0.01%
19
FFIV icon
506
F5
FFIV
$22.6B
$5K ﹤0.01%
23
FISV
507
Fiserv Inc
FISV
$26.8B
$5K ﹤0.01%
46
FOLD
508
DELISTED
Amicus Therapeutics
FOLD
$5K ﹤0.01%
482
-375
-44% -$3.84K
FTV icon
509
Fortive
FTV
$18.4B
$5K ﹤0.01%
97
GLW icon
510
Corning
GLW
$133B
$5K ﹤0.01%
130
HCAT icon
511
Health Catalyst
HCAT
$151M
$5K ﹤0.01%
96
-145
-60% -$7.91K
HCA icon
512
HCA Healthcare
HCA
$82.5B
$5K ﹤0.01%
21
HST icon
513
Host Hotels & Resorts
HST
$16.8B
$5K ﹤0.01%
282
ICUI icon
514
ICU Medical
ICUI
$3.93B
$5K ﹤0.01%
20
-36
-64% -$7.55K
JNPR
515
DELISTED
Juniper Networks
JNPR
$5K ﹤0.01%
188
MCRB icon
516
Seres Therapeutics
MCRB
$51.1M
$5K ﹤0.01%
37
+11
+42% +$2.15K
NEO icon
517
NeoGenomics
NEO
$1.82B
$5K ﹤0.01%
104
-160
-61% -$7.41K
NOK icon
518
Nokia
NOK
$57.4B
$5K ﹤0.01%
1,000
NUE icon
519
Nucor
NUE
$53.7B
$5K ﹤0.01%
54
PRAX icon
520
Praxis Precision Medicines
PRAX
$8.7B
$5K ﹤0.01%
17
-26
-60% -$7.05K
QRVO icon
521
Qorvo
QRVO
$7.89B
$5K ﹤0.01%
28
TAK icon
522
Takeda Pharmaceutical
TAK
$53.9B
$5K ﹤0.01%
277
-575
-67% -$9.65K
TDG icon
523
TransDigm Group
TDG
$66.8B
$5K ﹤0.01%
8
TMUS icon
524
T-Mobile US
TMUS
$207B
$5K ﹤0.01%
43
TVTX icon
525
Travere Therapeutics
TVTX
$5.23B
$5K ﹤0.01%
212
-239
-53% -$4.39K

Similar funds

Evolution Wealth Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Evolution Wealth Advisors held 696 positions worth $467M, down 5.2% from $492M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Evolution Wealth Advisors's Q3 2021 filing shows 70 new, 144 increased, 141 reduced and 33 closed positions. Its largest new stake was TMC The Metals Company: 377,000 shares worth $1.72M. The largest sale was Rodgers Silicon Valley Acquisition Corp. Unit, an estimated $7.13M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 4.1% of assets, down from 4.5% a quarter earlier, followed by Technology and Communication Services.

  • Evolution Wealth Advisors's largest Q3 2021 buy was TMC The Metals Company: 377,000 shares worth $1.72M.
  • Evolution Wealth Advisors added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2021, an estimated $6.94M increase.
  • Evolution Wealth Advisors's biggest Q3 2021 reduction was Vanguard Small-Cap ETF, cutting an estimated $6.89M.
  • Evolution Wealth Advisors fully exited Rodgers Silicon Valley Acquisition Corp. Unit in Q3 2021, selling an estimated $7.13M.
  • Evolution Wealth Advisors's ten largest holdings make up 57% of its $467M portfolio in Q3 2021.
  • Evolution Wealth Advisors opened 70 new positions and closed 33 in Q3 2021.
  • Evolution Wealth Advisors's portfolio value fell 5.2% quarter-over-quarter to $467M.

Based on Evolution Wealth Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.